Ropes Wealth Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Ropes Wealth Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-249	Closed	-$29K	–	873
2020 Q4	$29K	Hold	249	–	–	﹤0.01%	444
2020 Q3	$24K	Hold	249	–	–	﹤0.01%	415
2020 Q2	$31K	Hold	249	–	–	0.01%	355
2020 Q1	$22K	Hold	249	–	–	0.01%	358
2019 Q4	$26K	Hold	249	–	–	0.01%	392
2019 Q3	$29K	Buy	249 +40	+19%	+$6.07K	0.01%	392
2019 Q2	$36K	Hold	209	–	–	0.01%	368
2019 Q1	$35K	Hold	209	–	–	0.01%	368
2018 Q4	$20K	Buy	209 +140	+203%	+$18.4K	0.01%	379
2018 Q3	$12K	Buy	+69	New	+$9.95K	﹤0.01%	448

Other funds holding GWPH

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ropes Wealth Advisors's GWPH Position: Q1 2021 in Review

Ropes Wealth Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 249 shares — an estimated $29K sold.

Ropes Wealth Advisors first reported a position in GWPH in Q3 2018 and held it in 10 quarters. The position peaked at $36K in Q2 2019. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

Ropes Wealth Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
Ropes Wealth Advisors sold 249 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $29K.
Ropes Wealth Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2018 and held it in 10 quarters.
Ropes Wealth Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $36K in Q2 2019.
297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Ropes Wealth Advisors's 13F filing for Q1 2021, filed 12 May 2021.